Nutra Pharma Corp.
NPHC
$0.00
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -229.09% | 5.02% | 6.39% | -31.48% | 27.96% |
| Total Depreciation and Amortization | 8.56% | 7.34% | -8.00% | -8.13% | -8.26% |
| Total Amortization of Deferred Charges | 52.53% | 10.05% | 26.47% | 26.16% | -40.76% |
| Total Other Non-Cash Items | 1,587.17% | 19.09% | 108.24% | 105.43% | -61.73% |
| Change in Net Operating Assets | -168.92% | -56.10% | 43.78% | 17,062.50% | -46.73% |
| Cash from Operations | -136.57% | 4.30% | 122.68% | 49.89% | -84.48% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 1.49% | 89.80% | -- |
| Cash from Investing | -- | -90.07% | 1.49% | 89.80% | -- |
| Total Debt Issued | 87.63% | 70.41% | -42.83% | -29.47% | 50.79% |
| Total Debt Repaid | -23.15% | -37.57% | -2.90% | -25.44% | -12.29% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 138.61% | 101.17% | -204.73% | -51.91% | 106.76% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -- | -- | -- |